A 66-year-old man presented to our clinic with a 4-month history of edema of the right hand and arm (Figure 1). His symptoms began with numbness in the upper right arm and persistent pain behind the right scapula, which were accompanied by mild swelling on the dorsum of the right hand and wrist. For the first 3 months, the patient’s dominant concern was severe pain limiting his ability to raise his right arm. Consequently, 1 month before our evaluation, he sought orthopedic care and was diagnosed with adhesive capsulitis. However, the prescribed oral analgesics provided no relief.
Edema was prominent on the dorsum of the right hand and wrist at the time of evaluation.
Over the ensuing month after the orthopedic visit, the edema rapidly worsened and ascended toward the patient’s shoulder and neck, followed by the development of puffiness on the right side of his face. When specifically questioned, the patient reported a subtle unusual sensation during swallowing that had developed within the same period. His history included treated prostate cancer (in remission) and a 43-pack-year smoking history.
Physical examination revealed nonpitting and pitting edema of the right face, neck, and right upper extremity, with no localized warmth or erythema. Notably, the right shoulder appeared lower (drooping shoulder) than the left, and dilated superficial veins were prominent on the right upper chest wall (Figure 2). The drooping appearance was initially considered a potential antalgic posture. A firm, nontender induration was palpable in the right supraclavicular fossa. Shoulder mobility was limited primarily by intense scapular pain (abduction to 90°, flexion to 120°), and hand vein collapse during arm elevation could not be formally assessed because pain and neurogenic muscle weakness prevented the patient from maintaining an elevated posture.
Drooping right shoulder and dilated superficial veins (distended chest vein sign; arrows).
IMAGING AND LABORATORY TESTS
Superior vena cava syndrome was suspected, and a chest radiograph was obtained. It showed an ill-defined, hazy opacity overlying the right lung apex, with loss of normal lucency of subcutaneous fat in the supraclavicular region (Figure 3). Also, the apical pleura showed a subtle convex indentation toward the lung, suggesting a contiguous supraclavicular mass without apparent underlying rib destruction.
Chest radiograph showed an ill-defined, hazy opacity overlying the right lung apex with loss of subcutaneous fat lucency. The arrowhead indicates a subtle convex indentation of the apical pleura toward the lung, suggesting a contiguous mass without underlying rib destruction.
To confirm the presence of a physical mass obstructing venous return, urgent noncontrast computed tomography (CT) was performed, which confirmed a 65-mm mass in the right supraclavicular fossa obstructing the right internal jugular and subclavian veins (Figure 4A). Notably, despite the lack of contrast, the plain CT also showed tumorous wall thickening measuring 44 × 30 mm in the middle-to-lower thoracic esophagus, along with 2 smaller suspicious lesions in the upper thoracic esophagus (Figure 4B).
Noncontrast computed tomography images. (A) A 65-mm mass (asterisk) was noted in the right supraclavicular fossa, obstructing the internal jugular and subclavian veins. (B) A lower axial slice revealed a 44 × 30–mm mass with asymmetrical wall thickening in the thoracic esophagus (arrowhead), highly suggestive of primary esophageal carcinoma.
Laboratory testing showed a C-reactive protein level of 6.34 mg/dL (reference range ≤ 0.3) as well as an elevated level of the tumor marker cytokeratin fragment 21-1 (CYFRA 21-1) at 16.2 ng/mL (3.5); prostate-specific antigen was within normal range. Prompted by these CT findings and the patient’s subtle unusual swallowing sensation, upper gastrointestinal endoscopy was performed, which revealed a circumferential tumor in the mid-esophagus (29–33 cm from the incisors; Figure 5); biopsy confirmed keratinizing squamous cell carcinoma.
Upper gastrointestinal endoscopy showed the primary esophageal tumor.
MALIGNANT SUPERIOR VENA CAVA SYNDROME
The evaluation of progressive unilateral arm edema requires a broad differential diagnosis. While deep vein thrombosis often causes limb swelling, it does not explain the facial involvement or ascending progression observed in this patient. The definitive clinical clue to the cause of his arm edema was the distended chest vein sign, which is pathognomonic for superior vena cava syndrome or major brachiocephalic venous obstruction.1,2
The “drooping shoulder” in this case warranted careful anatomical consideration. While initially suspected to be an antalgic posture, it did not fit the diagnosis of adhesive capsulitis, which typically presents with global mechanical restriction of glenohumeral rotation without vascular signs. Its persistence alongside supraclavicular induration suggested malignant infiltration of the spinal accessory nerve (leading to hypotonia of the trapezius muscle) and the brachial plexus. The radiographic findings were critical early indicators, specifically, the ill-defined, hazy apical opacity, obscured subcutaneous fat planes, and convex pleural line. While a Pancoast tumor or mass originating from the chest wall, pleura, or deep subcutaneous tissues was initially considered, the absence of bone destruction on the radiograph shifted our focus toward a soft-tissue mass in the supraclavicular-apical interface.
Our diagnostic strategy focused on rapidly verifying whether the radiography findings represented a tumor causing superior vena cava syndrome.3 We opted for noncontrast CT as the immediate next step. This plain CT not only confirmed the supraclavicular mass but also directly showed the primary esophageal tumor and regional lesions, allowing us to proceed to definitive endoscopy. In reflecting on this process, point-of-care ultrasonography could have further optimized the initial workup at the bedside, providing immediate visualization of the mass effect on the subclavian vein and differentiating it from primary deep vein thrombosis, especially in a patient with cancer-associated hypercoagulability.
This case underscores the importance of active inquiry. The patient’s subtle unusual swallowing sensation, which was only elicited on direct questioning, was key to identifying primary esophageal malignancy as the source of the extensive nodal disease and superior vena cava syndrome.4 While lung cancer and lymphoma are the most common causes of malignant superior vena cava syndrome, esophageal carcinoma must be considered in patients with a significant smoking history.5 Clinicians must remain vigilant for these multimodal signs—venous, neurologic, and esophageal—to ensure timely diagnosis of occult malignancies.
DISCLOSURES
The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.
- Copyright © 2026 The Cleveland Clinic Foundation. All Rights Reserved.
REFERENCES
- 1↵QuencerKB. Superior vena cava syndrome: etiologies, manifestations, and treatments. Semin Intervent Radiol 2022; 39(3):292–303. doi:10.1055/s-0042-1753480
- 2↵AziziAH, ShafiI, ShahN, et al. Superior vena cava syndrome. JACC Cardiovasc Interv 2020; 13(24):2896–2910. doi:10.1016/j.jcin.2020.08.038
- 3↵YuJB, WilsonLD, Detterbeck FC. Superior vena cava syndrome—a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3(8):811–814. doi:10.1097/JTO.0b013e3181804791
- 4↵Wright K, Digby GC, Gyawali B, et al. Malignant superior vena cava syndrome: a scoping review. J Thorac Oncol 2023; 18(10):1268–1276. doi:10.1016/j.jtho.2023.04.019
- 5↵SookprasertA, SinchaiyaphumV, ChindaprasirtJ, WirasornK. Superior vena cava syndrome: clinical presentation and treatment outcome. J Med Assoc Thai 2018; 101(suppl 7):S149–S153.










